2-(3-carbazol-9-ylphenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzoxazole
C31H27BN2O3 — CID 147786465
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(3-carbazol-9-ylphenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzoxazole
2-(3-carbazol-9-ylphenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzoxazole (PubChem CID 147786465) has the molecular formula C31H27BN2O3 and a molecular weight of 486.38 g/mol. Its IUPAC name is 2-(3-carbazol-9-ylphenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzoxazole.
Molecular Properties
| Compound Name | 2-(3-carbazol-9-ylphenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzoxazole |
|---|---|
| PubChem CID | 147786465 |
| Molecular Formula | C31H27BN2O3 |
| Molecular Weight | 486.38 g/mol |
| Exact Mass | 486.21 |
| IUPAC Name | 2-(3-carbazol-9-ylphenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzoxazole |
| SMILES | CC1(C)OB(c2ccc3oc(-c4cccc(-n5c6ccccc6c6ccccc65)c4)nc3c2)OC1(C)C |
| InChI | InChI=1S/C31H27BN2O3/c1-30(2)31(3,4)37-32(36-30)21-16-17-28-25(19-21)33-29(35-28)20-10-9-11-22(18-20)34-26-14-7-5-12-23(26)24-13-6-8-15-27(24)34/h5-19H,1-4H3 |
| InChIKey | HIUAKXLIVJXJHC-UHFFFAOYSA-N |
| XLogP | 6.89 |
| TPSA | 49.42 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 486.38 |
| LogP ≤ 5 | 6.89 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 147786465 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.